Year: 2005
Type: article
Abstract: chemotherapeutic agents which have provided phase II activity in HRPC to date.the sub-to nanomolar concentration range, and comparison of the inhibitory concentrations, involves over-expression of the multidrug efflux pump, the KEYWORDS epothilones, chemotherapy, hormonerefractory prostate cancer
Source: British Journal of Urology
Authors: Manish S. Bhandari, Maha Hussain
Institutions: University of Michigan, Michigan Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2080808948